The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksSareum Regulatory News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 26.25
Bid: 26.00
Ask: 26.50
Change: 0.00 (0.00%)
Spread: 0.50 (1.923%)
Open: 26.00
High: 27.75
Low: 26.00
Prev. Close: 26.25
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second Price Monitoring Extn

17 Apr 2020 11:05

RNS Number : 0476K
Sareum Holdings PLC
17 April 2020
 

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
APMGZGMDGNKGGZM
Date   Source Headline
31st May 20177:00 amRNSSierra Oncology Granted US and EU Patents
25th May 20177:00 amRNSSierra Oncology to Present at ASCO Annual Meeting
9th May 20177:00 amRNSSareum to Present at BioTrinity 2017
9th Mar 20177:00 amRNSDirector Shareholding
20th Feb 20177:00 amRNSHalf-year Results
9th Feb 20177:00 amRNSNotice of Interim Results
9th Jan 201712:05 pmRNSMilestone Payment from Chk1 Licence Agreement
22nd Dec 20169:47 amRNSResult of General Meeting
15th Dec 201611:38 amRNSResult of AGM
6th Dec 20167:00 amRNSDirectors' Remuneration & General Meeting
29th Nov 20167:00 amRNSSareum to Present at AACR-NCI-EORTC Conference
21st Nov 20167:00 amRNSNotice of AGM
2nd Nov 20167:00 amRNSFinal Results
24th Oct 20167:00 amRNSSuccessful Outcome from TYK2 Feasibility Study
17th Oct 20167:00 amRNSJapan and Singapore Patent Grants
27th Sep 201612:02 pmRNSLicence agreement for Chk1 Inhibitor CCT245737
3rd Aug 20167:00 amRNSChina & HK Patent Grants for Sareum's Aurora+FLT3
28th Jul 20167:00 amRNSMovement in share price
23rd May 201612:00 pmRNSClinical Trials CHK1 Inhibitor CCT245737 to Open
17th May 20167:00 amRNSChange of Director
5th Apr 201610:38 amRNSCHK1 Approved for Clinical Trials
24th Mar 201611:54 amRNSPlacing
14th Mar 20167:00 amRNSIssue of Options
10th Mar 201612:55 pmRNSShare price movement
24th Feb 20167:01 amRNSResearch & Co-Development Collaborations Update
24th Feb 20167:00 amRNSHalf-Yearly Results for December 2015
1st Feb 20167:00 amRNSCHK1 Clinical Trial Application Submissions
15th Dec 201511:20 amRNSResult of AGM
15th Dec 20157:00 amRNSCHK1 Clinical Trial Applications
13th Nov 201510:15 amRNSNotice of AGM
26th Oct 20157:00 amRNSFinal Results
15th Sep 20157:00 amRNSUS and European Patent Grants for Aurora+FLT3
23rd Jul 20157:00 amRNSCHK1 Research Update
17th Jun 20157:00 amRNSFunding Award from Innovate UK
28th May 20157:00 amRNSPlacing
21st May 20157:00 amRNSSareum Launches New Website
12th May 20157:01 amRNSSareum to Present at BioTrinity 2015
7th May 20157:00 amRNSEarly Conclusion of Equity Swap Agreement
16th Mar 20157:00 amRNSChange of Adviser
20th Jan 20157:00 amRNSFurther US Patent Grant for Kinase Inhibitors
13th Oct 20148:20 amRNSHolding(s) in Company
1st Oct 20147:00 amRNSPromising Step in Psoriasis Drug Development
22nd Sep 20147:00 amRNSCHK1 Patent Update
2nd Jul 20147:00 amRNSJapanese Patent Grant for Kinase Inhibitors
30th Jun 20142:15 pmRNSTotal Voting Rights
26th Jun 20147:00 amRNSPreclinical Proof of Concept in TYK2 Programme
22nd Jan 20147:00 amRNSCHK1 Patent Update
25th Oct 20137:00 amRNSSareum to Present at London Investor Show
10th Sep 20127:00 amRNSFinancing
7th Aug 20121:20 pmRNSStmnt re Share Price Movement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.